InMed Pharmaceuticals Inc
NASDAQ:INM
| Market Cap (Intraday) | 13.53M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.67 |
| 50-Day MA | $1.63 |
| 200-Day MA | $2.76 |
InMed Pharmaceuticals Inc Stock, NASDAQ:INM
815 West Hastings Street, Suite 310, Vancouver, British Columbia V6C 1B4
Canada
Phone: +1.604.669.7207
Number of Employees:
Description
InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research and development of novel. It also involves in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.